We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.62%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
326
Evercore Wealth Management
New York
$116K +$105K +2,137 New
RWA
327
Ropes Wealth Advisors
Massachusetts
$113K +$102K +2,073 New
CBT
328
Central Bank & Trust
Kentucky
$113K +$102K +2,077 New
MFBTD
329
MB Financial Bank - Trust Department
Illinois
$111K +$100K +2,036 New
PIM
330
Platinum Investment Management
Australia
$108K +$98.5K +2,000 New
EDRH
331
Edmond de Rothschild Holding
Switzerland
$96K +$87K +1,767 New
WOC
332
West Oak Capital
California
$87.7K +$79.4K +1,611 New
NAMA
333
Nikko Asset Management Americas
New York
$84K +$76.3K +1,550 New
BVDMP
334
Bedrijfstakpensioenfonds Voor De Media PNO
Netherlands
$81K +$73.1K +1,485 New
FHA
335
First Horizon Advisors
Tennessee
$80K +$68K +1,380 New
BBHC
336
Brown Brothers Harriman & Co
New York
$80K +$72.5K +1,472 New
YWP
337
YorkBridge Wealth Partners
New York
$77K +$65.6K +1,332 New
WIM
338
Westside Investment Management
California
$70.1K +$64.3K +1,305 New
MA
339
MUFG Americas
New York
$66K +$60.1K +1,221 New
TCOV
340
Trust Company of Vermont
Vermont
$65K +$58.7K +1,191 New
GC
341
Gruss & Co
Florida
$61.3K +$55.4K +1,125 New
LNB
342
Ledyard National Bank
$61K +$54.8K +1,113 New
CLOS
343
Compagnie Lombard Odier SCmA
Switzerland
$61K +$55.1K +1,119 New
VanEck Associates
344
VanEck Associates
New York
$61K +$55.6K +1,129 New
SCM
345
Segantii Capital Management
Hong Kong
$59K +$53.5K +1,087 New
SAM
346
Shell Asset Management
Netherlands
$58K +$52.5K +1,066 New
WT
347
Whittier Trust
California
$54K +$49.4K +1,002 New
MCM
348
Manchester Capital Management
Vermont
$53K +$48.1K +976 New
WEC
349
Winslow Evans & Crocker
Massachusetts
$44.1K +$39.9K +810 New
OMCS
350
Old Mutual Customised Solutions
South Africa
$44K +$39.4K +800 New
12 13
14
15 16

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.